TCF7 and tuberculosis: In both acute and chronic infection cohorts—including tuberculosis—failure to establish SAS‐1high‐MAS‐1low immune profiles during recovery or therapy predicted elevated triad burden, reduced TCF7 expression, and poorer clinical outcomes, including treatment failure or heightened risk of active tuberculosis (Figures S5c and S9).